Risk factor patterns for cryptorchidism and hypospadias

Epidemiology

Volumn 10, Issue 4, 1999, Pages 364-369

  Akre, Olof ^a   Lipworth, Loren ^a,b   Cnattingius, Sven ^a   Sparén, Pär ^a   Ekbom, Anders ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cryptorchidism; Estrogen; Etiology; Hypospadias; Intrauterine growth retardation; Pregnancy; Sex hormones

Indexed keywords

ARTICLE; CHILD; CONTROLLED STUDY; CRYPTORCHISM; DISEASE ASSOCIATION; DISEASE RESISTANCE; ENVIRONMENTAL EXPOSURE; HUMAN; HYPOSPADIAS; MAJOR CLINICAL STUDY; MALE; PARITY; PREECLAMPSIA; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR; SMALL FOR DATE INFANT; SWEDEN;

EID: 0033039130     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-199907000-00005     Document Type: Article

References (37)

1. Cryptorchidism: an apparent substantial increase since 1960. John Radcliffe Hospital Cryptorchidism Study Group. Br Med J (Clin Res Ed) 1986;29: 1401-1404.
2. World Health Organization. Congenital Malformations Worldwide: A Report from the International Clearinghouse for Birth Defects Monitoring Systems. Oxford: Elsevier, 1991
3. Sharpe RM, Skakkebaek NE. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 1993;29:1392-1395.
4. Bromwich P, Cohen J, Stewart I, Walker A. Decline in sperm counts: an artefact of changed reference range of "normal"?. BMJ 1994;2:19-22.
5. James WH. Secular trends in monitors of reproductive hazard. Hum Reprod 1997;12:417-421.
6. Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P, Guillette Jr LJ, Jegou B, Jensen TK, Jouannet P, Keiding N, Leffers H, McLachlan JA, Meyer O, Muller J, Rajpert-De Meyts E, Scheike T, Sharpe R, Sumpter J, Skakkebaek NE. Male reproductive health and environmental xenoestrogens. Environ Health Perspect 1996;104:741-803.
7. Guyton AC. Textbook of medical physiology, 8th ed. Philadelphia: W. B. Saunders, 1991.
8. Panagiotopoulou K, Katsouyanni K, Petridou E, Garas Y, Tzonou A, Trichopoulos D. Maternal age, parity, and pregnancy estrogens. Cancer Causes Control 1990;1:119-124.
9. Petridou E, Panagiotopoulou K, Katsouyanni K, Spanos E, Trichopoulos D. Tobacco smoking, pregnancy estrogens, and birth weight. Epidemiology 1990;1:247-250.
10. Rosing U, Carlström K. Serum levels of unconjugated and total oestrogens and dehydroepiandrosterone, progesterone and urinary oestriol excretion in pre-eclampsia. Gynecol Obstet Invest 1984;18:199-205.
11. Kitawaki J, Inoue S, Tamura T, Yamamoto T, Honjo H, Higashiyama T, Osawa Y, Okada H. Cigarette smoking during pregnancy lowers aromatase cytochrome P-450 in the human placenta. J Steroid Biochem Mol Biol 1993;45:485-491.
12. Barbieri RL, Gochberg J, Ryan KJ. Nicotine, cotinine, and anabasine inhibit aromatase in human trophoblast in vitro. J Clin Invest 1986;77:1727-1733.
13. Aberg A, Lindmark G. Competence and compliance in antenatal care. Experience from Sweden. Int J Technol Assess Health Care 1992;8(suppl): 1:20-24.
14. National Board of Health and Welfare, Centre for Epidemiology. Medical Birth Registration in 1993. Stockholm: Official Statistics of Sweden, 1996:4.
15. Nyrén O, Yin L, Josefsson S, McLaughlin JK, Blot WJ, Engqvist M, Hakelius L, Boice JD Jr., Adami HO. Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ 1998;316:417-422.
16. Högberg U, Larsson N. Early dating by ultrasound and perinatal outcome. Acta Obstet Gynecol Scand 1997;76:907-912.
17. Marsal K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996;85:843-848.
18. Rothman KJ, Greenland S. Modern Epidemiology, 2nd ed. Philadelphia: Lippincott-Raven Publishers, 1998.
19. Angerpointner TA. Hypospadias - genetics, epidemiology and other possible aetiological influences. Z Kinderchir 1984;39:112-118.
20. Benson Jr RC, Beard CM, Kelalis PP, Kurland LT. Malignant potential of the cryptorchid testis. Mayo Clin Proc 1991;66:372-378.
21. Berkowitz GS, Lapinski RH, Godbold JH, Dolgin SE, Holzman IR. Maternal and neonatal risk factors for cryptorchidism. Epidemiology 1995;6:127-131.
22. Calzolari E, Contiero MR, Roncarati E, Mattiuz PL, Volpato S. Aetiological factors in hypospadias. J Med Genet 1986;23:333-337.
23. Kallen B, Castilla EE, Kringelbach M, Lancaster PA, Martinez-Frias ML, Mastroiacovo P, Mutchinick O, Robert E. Parental fertility and infant hypospadias: an international case-control study. Teratology 1991;44:629-634.
24. Monteleone Neto R, Castilla EE, Paz JE. Hypospadias: an epidemiological study in Latin America. Am J Med Genet 1981;10:5-19.
25. Davies TW, Williams DR, Whitaker RH. Risk factors for undescended testis. Int J Epidemiol 1986;15:197-201.
26. Depue RH. Maternal and gestational factors affecting the risk of cryptorchidism and inguinal hernia. Int J Epidemiol 1984;13:311-318.
27. Swerdlow AJ, Wood KH, Smith PG. A case-control study of the aetiology of cryptorchidism. J Epidemiol Community Health 1983;37:238-244.
28. Sharpe RM. Reproductive biology. Another DDT connection. Nature 1995; 15:538-539.
29. Duncan SL, Ginz B, Wahab H. Use of ultrasound and hormone assays in the diagnosis, management, and outcome of twin pregnancy. Obstet Gynecol 1979;53:367-372.
30. Hutson JM, Baker M, Terada M, Zhou B, Paxton G. Hormonal control of testicular descent and the cause of cryptorchidism. Reprod Fertil Dev 1994; 6:151-156.
31. Bauer MK, Harding JE, Bassett NS, Breier BH, Oliver MH, Gallaher BH, Evans PC, Woodall SM, Gluckman PD. Fetal growth and placental function. Mol Cell Endocrinol 1998;140:115-120.
32. Burton GJ, Palmer ME, Dalton KJ. Morphometric differences between the placental vasculature of non-smokers, smokers and ex-smokers. Br J Obstet Gynaecol 1989;96:907-915.
33. Cnattingius S, Haglund B, Kramer MS. Differences in late fetal death rates in association with determinants of small-for-gestational-age fetuses: population-based cohort study. BMJ 1998;316:1483-1487.
34. Starzyk KA, Salafia CM, Pezzullo JC, Lage JM, Parkash V, Vercruysse L, Hanssens M, Pijnenborg R. Quantitative differences in arterial morphometry define the placental bed in preeclampsia. Hum Pathology 1997;28:353-358.
35. McBride ML, Van den Steen N, Lamb CW, Gallagher RP. Maternal and gestational factors in cryptorchidism. Int J Epidemiol 1991;20:964-970.
36. Beard CM, Melton LJ3d, O'Fallon WM, Noller KL, Benson RC. Cryptorchism and maternal estrogen exposure. Am J Epidemiol 1984;120:707-716.
37. Berkowitz GS, Lapinski RH. Risk factors for cryptorchidism: a nested case-control study. Paediatr Perinat Epidemiol 1996;10:39-51.